Showing results (11-20 of 112) with videos related to
Sort By:
Pageof 12
Bioorganic & Medicinal Chemistry Letters|February 21, 2021
Identification of a new class of HBV capsid assembly modulatorScott D Kuduk, Bart Stoops, Richard Alexander, et al.Journal of Molecular Biology|December 16, 2003
Inhibition of a mitotic motor protein: where, how, and conformational consequencesYouwei Yan, Vinod Sardana, Bei Xu, et al.Antimicrobial Agents and Chemotherapy|October 31, 2018
Preclinical Characterization of NVR 3-778, a First-in-Class Capsid Assembly Modulator against Hepatitis B VirusAngela M Lam, Christine Espiritu, Robert Vogel, et al.Bioorganic & Medicinal Chemistry Letters|June 1, 2022
Diazepinone HBV capsid assembly modulatorsScott D Kuduk, Lindsey G DeRatt, Bart Stoops, et al.Bioorganic & Medicinal Chemistry Letters|December 7, 2007
Development of potent, allosteric dual Akt1 and Akt2 inhibitors with improved physical properties and cell activityZhijian Zhao, Ronald G Robinson, Stanley F Barnett, et al.Bioorganic & Medicinal Chemistry Letters|May 6, 2003
2,4-disubstituted pyrimidines: a novel class of KDR kinase inhibitorsPeter J Manley, Adrienne E Balitza, Mark T Bilodeau, et al.Bioorganic & Medicinal Chemistry Letters|February 26, 2008
Optimization of 2,3,5-trisubstituted pyridine derivatives as potent allosteric Akt1 and Akt2 inhibitorsJohn C Hartnett, Stanley F Barnett, Mark T Bilodeau, et al.Bioorganic & Medicinal Chemistry Letters|March 5, 2005
Nonpeptide alpha(v)beta3 antagonists: identification of potent, chain-shortened 7-oxo RGD mimeticsAmy E Zartman, Le T Duong, Carmen Fernandez-Metzler, et al.Current Medicinal Chemistry|March 23, 2004
Property-based design of KDR kinase inhibitorsMark E Fraley, William F Hoffman, Kenneth L Arrington, et al.ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of naphthyl-fused 5-membered lactams as a new class of m1 positive allosteric modulatorsZhi-Qiang Yang, Youheng Shu, Lei Ma, et al.Pageof 12